These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26738763)

  • 1. Epidemiologic and Microbiologic Characteristics of Occult Bacteremia Among Febrile Children in Southern Israel, Before and After Initiation of the Routine Antipneumococcal Immunization (2005-2012).
    Ribitzky-Eisner H; Minuhin Y; Greenberg D; Greenberg N; Chodick G; Craiu M; Leibovitz E
    Pediatr Neonatol; 2016 Oct; 57(5):378-384. PubMed ID: 26738763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Epidemiologic, Microbiologic and Clinical Picture of Bacteremia among Febrile Infants and Young Children Managed as Outpatients at the Emergency Room, before and after Initiation of the Routine Anti-Pneumococcal Immunization.
    Leibovitz E; David N; Ribitzky-Eisner H; Abo Madegam M; Abuabed S; Chodick G; Maimon M; Fruchtman Y
    Int J Environ Res Public Health; 2016 Jul; 13(7):. PubMed ID: 27447651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occult bacteremia etiology following the introduction of 13-valent pneumococcal conjugate vaccine: a multicenter study in Spain.
    Hernández-Bou S; Gómez B; Mintegi S; García-García JJ;
    Eur J Clin Microbiol Infect Dis; 2018 Aug; 37(8):1449-1455. PubMed ID: 29736610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumococcal bacteremia among infants with fever without known source before and after introduction of pneumococcal conjugate vaccine in the Basque Country of Spain.
    Benito-Fernández J; Raso SM; Pocheville-Gurutzeta I; SánchezEtxaniz J; Azcunaga-Santibañez B; Capapé-Zache S
    Pediatr Infect Dis J; 2007 Aug; 26(8):667-71. PubMed ID: 17848875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumococcal nasopharyngeal carriage in children <5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern Israel.
    Ben-Shimol S; Givon-Lavi N; Greenberg D; Dagan R
    Hum Vaccin Immunother; 2016; 12(2):268-76. PubMed ID: 26430921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occult Bacteremia: Should We Look for the Needle in the Haystack?
    Baram N; Megged O; Weiser G
    Isr Med Assoc J; 2016 Nov; 18(11):649-651. PubMed ID: 28466611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of occult bacteremia among highly febrile young children in the era of the pneumococcal conjugate vaccine: a study from a Children's Hospital Emergency Department and Urgent Care Center.
    Stoll ML; Rubin LG
    Arch Pediatr Adolesc Med; 2004 Jul; 158(7):671-5. PubMed ID: 15237067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumococcal bacteremia in febrile infants presenting to the emergency department 8 years after the introduction of pneumococcal conjugate vaccine in the Basque Country of Spain.
    Benito-Fernández J; Mintegi S; Pocheville-Gurutzeta I; Sánchez Etxaniz J; Gómez Cortés B; Hernández Almaraz JL
    Pediatr Infect Dis J; 2010 Dec; 29(12):1142-4. PubMed ID: 20592642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine.
    Kaplan SL; Barson WJ; Lin PL; Romero JR; Bradley JS; Tan TQ; Hoffman JA; Givner LB; Mason EO
    Pediatr Infect Dis J; 2013 Mar; 32(3):203-7. PubMed ID: 23558320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteremia in feverish children presenting to the emergency department: a retrospective study and literature review.
    Bressan S; Berlese P; Mion T; Masiero S; Cavallaro A; Da Dalt L
    Acta Paediatr; 2012 Mar; 101(3):271-7. PubMed ID: 21950707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Retrospective Study of the Impact of Pneumococcal Conjugate Vaccine-13 Immunization in a Northern Israel Hospital.
    Zaitoon H; Bamberger E; Yaniv L; Mendelson B; Srugo I; Chistyakov I
    Isr Med Assoc J; 2020 Feb; 22(2):71-74. PubMed ID: 32043321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteremia in Children 3 to 36 Months Old After Introduction of Conjugated Pneumococcal Vaccines.
    Greenhow TL; Hung YY; Herz A
    Pediatrics; 2017 Apr; 139(4):. PubMed ID: 28283611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergency department epidemiology of pneumococcal bacteremia in children since the institution of widespread PCV7 vaccination.
    Mistry RD; Wedin T; Balamuth F; McGowan KL; Ellison AM; Nelson KA; McLoughlin RJ; Alpern ER
    J Emerg Med; 2013 Dec; 45(6):813-20. PubMed ID: 23992851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA).
    Shibl AM; Memish ZA; Al-Kattan KM
    Vaccine; 2012 Dec; 30 Suppl 6():G32-6. PubMed ID: 23228355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early impact of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine on IPD in Israeli children <5 years: an active prospective nationwide surveillance.
    Ben-Shimol S; Greenberg D; Givon-Lavi N; Schlesinger Y; Somekh E; Aviner S; Miron D; Dagan R
    Vaccine; 2014 Jun; 32(27):3452-9. PubMed ID: 24690148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the 13-valent pneumococcal conjugate vaccine (PCV13) on acute mastoiditis in children in southern Israel: A 12-year retrospective comparative study (2005-2016).
    Sapir A; Ziv O; Leibovitz E; Kordeluk S; Rinott E; El-Saied S; Greenberg D; Kaplan DM
    Int J Pediatr Otorhinolaryngol; 2021 Jan; 140():110485. PubMed ID: 33168224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analysis of pediatric blood cultures in the postpneumococcal conjugate vaccine era in a community hospital emergency department.
    Sard B; Bailey MC; Vinci R
    Pediatr Emerg Care; 2006 May; 22(5):295-300. PubMed ID: 16714955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Near-elimination of otitis media caused by 13-valent pneumococcal conjugate vaccine (PCV) serotypes in southern Israel shortly after sequential introduction of 7-valent/13-valent PCV.
    Ben-Shimol S; Givon-Lavi N; Leibovitz E; Raiz S; Greenberg D; Dagan R
    Clin Infect Dis; 2014 Dec; 59(12):1724-32. PubMed ID: 25159581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study.
    Waight PA; Andrews NJ; Ladhani SN; Sheppard CL; Slack MP; Miller E
    Lancet Infect Dis; 2015 May; 15(5):535-43. PubMed ID: 25801458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive Pneumococcal Disease Following the Introduction of 13-Valent Conjugate Vaccine in Children in New York City From 2007 to 2012.
    Farnham AC; Zimmerman CM; Papadouka V; Konty KJ; Zucker JR; Nattanmai GV; Jose S; Rosen JB
    JAMA Pediatr; 2015 Jul; 169(7):646-52. PubMed ID: 25938798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.